Skip to content

Clinical trials

Phase 3 Prediabetic State trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prediabetic State Phase: Phase 3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20132
20151
20161
20171
20181
20191
20211
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
RISE Study Group2
Tufts Medical Center2
Woman's2
Brigham and Women's Hospital1
Emory University1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Novartis1
Sanofi1
University of New Mexico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prediabetic State16
Diabetes Mellitus, Type 25
Obesity5
Overweight4
Diabetes Mellitus3
Glucose Intolerance3
Nutrition Disorders2
Obesity, Abdominal2
Cystic Fibrosis1
Diabetes, Gestational1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.